PAF promotes stemness and radioresistance of glioma stem cells

Proceedings of the National Academy of Sciences of the United States of America
Derrick Sek Tong OngRonald A DePinho

Abstract

An integrated genomic and functional analysis to elucidate DNA damage signaling factors promoting self-renewal of glioma stem cells (GSCs) identified proliferating cell nuclear antigen (PCNA)-associated factor (PAF) up-regulation in glioblastoma. PAF is preferentially overexpressed in GSCs. Its depletion impairs maintenance of self-renewal without promoting differentiation and reduces tumor-initiating cell frequency. Combined transcriptomic and metabolomic analyses revealed that PAF supports GSC maintenance, in part, by influencing DNA replication and pyrimidine metabolism pathways. PAF interacts with PCNA and regulates PCNA-associated DNA translesion synthesis (TLS); consequently, PAF depletion in combination with radiation generated fewer tumorspheres compared with radiation alone. Correspondingly, pharmacological impairment of DNA replication and TLS phenocopied the effect of PAF depletion in compromising GSC self-renewal and radioresistance, providing preclinical proof of principle that combined TLS inhibition and radiation therapy may be a viable therapeutic option in the treatment of glioblastoma multiforme (GBM).

References

Feb 5, 2000·Journal of Neurosurgery·S LalF F Lang
Jun 8, 2002·Annual Review of Neuroscience·Nicholas Gaiano, Gord Fishell
Jul 20, 2002·Journal of Neuro-oncology·Fazilet KayaselçukTahsin Erman
Apr 15, 2003·Toxicology and Applied Pharmacology·Tsung-Ming ShihJohn H McDonough
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Houman D HemmatiHarley I Kornblum
Oct 8, 2004·Molecular Cancer·Patrizia TuniciGaetano Finocchiaro
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Mar 15, 2006·Nature Cell Biology·Tony T HuangAlan D D'Andrea
Jan 2, 2007·Current Biology : CB·Virginie ClementAriel Ruiz i Altaba
Mar 18, 2008·Molecular Cell·Adelina A DaviesHelle D Ulrich
May 12, 2009·Cell Stem Cell·Myung Jin SonHoward A Fine
May 11, 2010·Cell Stem Cell·Justin D LathiaJeremy N Rich
Jun 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Michael J EmanueleStephen J Elledge
Jul 20, 2011·The Journal of Cell Biology·Xiomaris M Cotto-RiosTony T Huang
Aug 17, 2011·The Journal of Experimental Medicine·Yacine M AmraniLisa K Denzin
Jan 20, 2012·Nature·Christopher J Lord, Alan Ashworth
Sep 24, 2013·Molecular Cell·Hae-Yun JungJae-Il Park
Feb 18, 2014·Nature Chemical Biology·Qin LiangZhihao Zhuang
Sep 11, 2014·Molecular Oncology·Ross CarruthersAnthony J Chalmers
Mar 13, 2015·Nature Communications·Alfredo De BiasioFrancisco J Blanco
Jun 26, 2015·Genes & Development·Justin D LathiaJeremy N Rich
Mar 24, 2016·Cancer Discovery·Kristina M GodekDuane A Compton
Mar 28, 2017·Nature Neuroscience·Xiuxing WangJeremy N Rich

❮ Previous
Next ❯

Citations

Nov 15, 2017·Current Opinion in Oncology·Giorgio Seano
Jul 9, 2020·International Journal of Molecular Sciences·Susannah HallalKimberley Louise Alexander-Kaufman
Sep 20, 2018·Nature Reviews. Cancer·Nikki K LytleTannishtha Reya
Sep 10, 2020·Cancers·Md Yousuf AliCorinne E Griguer
Nov 25, 2020·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Yamei ChenXiao Hu
Jan 19, 2021·CNS Neuroscience & Therapeutics·Hai YuMinxue Lian
Aug 10, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xingjie GaoWeifeng Mao
Aug 13, 2021·Frontiers in Oncology·Giuliana CataraDaniela Spano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.